ResMed|
RMD stock analysis · Health Care · Health Care Equipment
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -10.2% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
14 industry peers · median 28.3×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 20.1× · -39.0% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · parent-equity fallback (scope limitation)
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Annual basis · read assumptions below
How this is calculated ↗Accrual quality
Parent-earnings fallback versus consolidated cash flow · scope limitation
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $219.48 | $239.47 | $260.97 |
| 10.0% | $160.83 | $174.98 | $190.18 |
| 12.0% | $126.88 | $137.68 | $149.26 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2026-06-30 | 5.7B | 1.5B | 1.8B | 156.3M | 9B |
| 2025-06-30 | 5.1B | 1.4B | 1.8B | 89.9M | 8.2B |
| 2024-06-30 | 4.7B | 1B | 1.4B | 99.5M | 6.9B |
| 2023-06-30 | 4.2B | 897.6M | 693.3M | 119.7M | 6.8B |
| 2022-06-30 | 3.6B | 779.4M | 351.1M | 134.8M | 5.1B |
| 2021-06-30 | 3.2B | 474.5M | 736.7M | 102.7M | 4.7B |
| 2020-06-30 | 3B | 621.7M | 802.3M | 95.3M | 4.6B |
| 2019-06-30 | 2.6B | 404.6M | 459.1M | 68.7M | 4.1B |
| 2018-06-30 | 2.3B | 315.6M | 505M | 62.6M | 3.1B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 5.1B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-08-13 |
| netIncome | 1.4B | NetIncomeLoss Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2026-08-13 |
| Parent/common earnings proxy | 1.4B | NetIncomeLoss | 2026-08-13 |
| cfo | 1.8B | NetCashProvidedByUsedInOperatingActivities | 2026-08-13 |
| capex | 89.9M | PaymentsToAcquirePropertyPlantAndEquipment | 2026-08-13 |
| operatingIncome | 1.7B | OperatingIncomeLoss | 2026-08-13 |
| assets | 8.2B | Assets | 2026-08-13 |
| equity | 6B | StockholdersEquity Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2026-08-13 |
| Parent book equity proxy | 6B | StockholdersEquity | 2026-08-13 |
| debt | 658.4M | LongTermDebt | 2026-08-13 |
| shortDebt | 9.9M | ShortTermBorrowings | 2026-08-13 |
| cash | 1.2B | CashAndCashEquivalentsAtCarryingValue | 2026-08-13 |
| shares | 147.3M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-08-13 |
| dividends | 310.9M | PaymentsOfDividends | 2026-08-13 |
| buybacks | 300M | PaymentsForRepurchaseOfCommonStock | 2026-08-13 |
| issuance | 74.4M | ProceedsFromIssuanceOfCommonStock | 2026-08-13 |